Amicus Therapeutics, Inc.
News
Victory Capital Management Inc. Raises Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD)
Zolmax Victory Capital Management Inc. lifted its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 17.9% in the second quarter, according to the company in its most recent 13F filing...\n more…
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Rating of "Moderate Buy" by Brokerages
Ticker Report Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Get Free Report) have earned an average rating of "Moderate Buy" from the nine ratings firms that are currently covering the stock, Marketbeat...\n more…
Amicus Therapeutics (NASDAQ:FOLD) Earns Buy Rating from Analysts at Jefferies Financial Group
Ticker Report Jefferies Financial Group began coverage on shares of Amicus Therapeutics (NASDAQ:FOLD - Free Report) in a research report sent to investors on Friday, MarketBeat reports. The firm issued a buy...\n more…
Zurcher Kantonalbank Zurich Cantonalbank Boosts Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD)
Ticker Report Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 6.1% during the second quarter, HoldingsChannel reports. The fund...\n more…
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks Investment Research For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The research service...\n more…
Amicus Therapeutics Breaks Below 200-Day Moving Average - Notable for FOLD
Market News Video In trading on Wednesday, shares of Amicus Therapeutics Inc (FOLD) crossed below their 200 day moving average of 11.40, changing hands as low as 11.32 per share. Amicus Therapeutics Inc...\n more…